933PD - The exposure-response relationship of niraparib in patients with gBRCAmut and non-gBRCAmut: Results from the ENGOT-OV16/NOVA Trial

J Wang, X Wang + Show 18 more

Open Access

https://doi.org/10.1093/annonc/mdx372.003

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2017
Citations: 7	License type: publisher-specific-oa

Affiliation: Tesaro (United States), Cedars-Sinai Medical Center, Centre Antoine Lacassagne, BC Cancer Agency, Universität Hamburg, University Medical Center Hamburg-Eppendorf, Sarah Cannon, University of Oklahoma, McGill University Health Centre, Dana-Farber Cancer Institute, Institute of Cancer Research of Montpellier, Nordic Society of Gynecologic Oncology, Rigshospitalet, Copenhagen University Hospital, Northside Hospital, Spanish Ovarian Cancer Research Group, Hospital Universitario La Paz

#Niraparib In Patients #NOVA Trial + Show 1 more

Abstract
Full-Text PDF
Similar Papers

Abstract

933PD - The exposure-response relationship of niraparib in patients with gBRCAmut and non-gBRCAmut: Results from the ENGOT-OV16/NOVA Trial

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export